Association for the Advancement of Medical Instrumentation Highlights Taiwan’s Potential in AI and Smart Healthcare Collaboration

The 9th Healthcare Expo Taiwan will be held at Taipei Nangang Exhibition Center, Hall 1 from December 4th to 7th, expecting nearly 40 overseas industry associations to visit Taiwan in search of collaboration opportunities with Taiwan’s medical and biotechnology sectors. Ahead of the event, the organizers have launched a special “International Associations Interview Series,” featuring first-time visiting representatives who share their perspectives on Taiwan’s market potential and cooperation opportunities, helping domestic companies prepare for early business matchmaking.

AAMI Vice President: Taiwan Can Contribute to Global AI and Medical Device Standards

In an exclusive pre-event interview, Timothy Hsu, Vice President of the Association for the Advancement of Medical Instrumentation (AAMI), shared AAMI’s global role in shaping medical device standards and his insights into Taiwan’s potential as a strategic partner in AI and smart healthcare development.

A Core Organization Shaping Global Medical Device Standards

Founded in 1967, AAMI has been the leading standards body for U.S. medical devices for nearly six decades. With more than 14,000 members worldwide, its network includes multinational corporations such as Johnson & Johnson, Medtronic, and GE Healthcare, as well as hospitals, government agencies, and professional experts.

AAMI also serves as the U.S. representative secretariat to the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC) for medical devices and healthcare technologies, playing a critical role in global standards harmonization. As such, it is widely regarded as one of the key sources of international medical technology standards.

Taiwan’s Technological Strengths Position It for Leadership in AI Standardization

Tim noted that his visit aims to establish closer collaboration between Taiwan and the U.S. in the area of standards development. He emphasized that Taiwan’s strong foundations in ICT and semiconductor manufacturing underpin its innovative strength in AI and smart healthcare, enabling it not only to benefit from global standards but also to actively contribute to the standard’s formation for global AI and medical devices.

He highlighted several key areas of interest where Taiwan could play a major role:

1. Health Technology: Telehealth, AI-assisted diagnostics, wearable devices, cloud-based health management
2. Semiconductor Design & Manufacturing: Incorporating cybersecurity and data-protection principles at the chip design stage
3. Medical Device Manufacturing: High-precision products such as cardiac stents, artificial valves, and orthopedic implants
4. Medical Databases & Cloud Services: Data storage, computation, and AI algorithm validation providers
5. Academic and Research Institutions: Leading universities such as NTU and TMU contributing validation data and reference models for standard setting
   

Tim added that by participating early in international standardization efforts, Taiwanese companies can anticipate regulatory trends, strengthen compliance readiness, and gain a sustainable competitive edge in AI-driven healthcare innovation.

“Standard-Setting Is Market Power”—AAMI Invites Taiwanese Companies to Join

“In ICT, whoever defines the standard defines the market, and the same applies to medical technology,”Tim explained.

Given the rapid evolution of adaptive and generative AI algorithms, lack of unified standards could increase regulatory burdens and slow innovation. AAMI therefore encourages technologically advanced companies worldwide to join the committees and shape future frameworks together.

Besides traditional med-tech giants, Apple, Google and other high-tech leaders are also AAMI members. Taiwan, having become a member of the International Council for Harmonisation (ICH) in 2020, should further extend its influence into emerging medical technologies and AI standardization, Tim said.

Even with some limitations in the formal international representation, Taiwanese companies and institutions can still join AAMI directly, aligning with U.S. regulatory trends and participating in the global standard-setting ecosystem. Tim also noted that some Taiwanese firms at CES have already promoted products developed “in compliance with AAMI standards,” marking a promising start for deeper engagement with AAMI.

Strengthening U.S.–Taiwan Cooperation in Standards for the Future of Smart Healthcare

Reflecting on Taiwan’s outstanding pandemic response, Tim praised the government’s ability to combine national health insurance data with technology-driven decision-making, demonstrating a high level of data integration and governance maturity.

As an AAMI vice president with Taiwanese heritage, Tim described this visit as especially meaningful. He hopes to foster closer collaboration between Taiwan and the U.S. in medical device standards and regulatory alignment—accelerating the global advancement of smart healthcare.

“Taiwan’s active participation will make AAMI standards more globally representative and diverse,” Tim concluded.

【Register Now for Fast Entry ▷ ▷ ▷】